Rosmarinic acid, a serious part of rosemary, is a polyphenolic compound with potential neuroprotective results. Asreducing the synaptic launch of glutamate is essential to reaching neuroprotectant’s pharmacotherapeutic results, the impact of rosmarinic acid on glutamate launch was investigated in rat cerebrocortical nerve terminals (synaptosomes). Rosmarinic acid depressed the 4-aminopyridine (4-AP)-induced glutamate launch in a concentration-dependent method. The removing of extracellular calcium and the blockade of vesicular transporters prevented the inhibition of glutamate launch by rosmarinic acid.
Rosmarinic acid decreased 4-AP-induced intrasynaptosomal Ca2+ elevation. The inhibition of N-, P/Q-type Ca2+ channels and the calcium/calmodulin-dependent kinase II (CaMKII) prevented rosmarinic acid from having results on glutamate launch. Rosmarinic acid additionally decreased the 4-AP-induced activation of CaMKII and the next phosphorylation of synapsin I, the primary presynaptic goal of CaMKII. As well as, immunocytochemistry confirmed the presence of GABAA receptors. GABAA receptor agonist and antagonist blocked the inhibitory impact of rosmarinic acid on 4-AP-evoked glutamate launch.
Docking knowledge additionally revealed that rosmarinic acid shaped a hydrogen bond with the amino acid residues of GABAA receptor. These outcomes instructed that rosmarinic acid prompts GABAA receptors in cerebrocortical synaptosomes to lower Ca2+ inflow and CaMKII/synapsin I pathway to inhibit the evoked glutamate launch.
Encapsulation of bioactive compounds from byproducts of two species of passionflowers: analysis of the physicochemical properties and managed launch in a gastrointestinal mannequin
This examine aimed to guage the discharge of energetic parts with antioxidant and antihypertensive capability from encapsulated extracts of the peel and seeds of Gulupa (Passiflora edulis f. edulis) and Cholupa (Passiflora maliformis) in an in vitro gastrointestinal digestion mannequin. Microencapsulated extracts have been ready with enzymatically modified rice starch because the encapsulating materials and ethanol extracts of seeds and peel of P. edulis f. edulis and P. maliformis as encapsulated materials. Microcapsule characterization was carried out by scanning electron microscopy with values of 4.54-5.13 μm and ξ potential values of -6.34 mV and -6.66 mV.
Dynamic gentle scattering (DLS) evaluation was performed with polydispersion values from 1.33 to 1.51, and dispersion stability evaluation was additionally performed. The overall phenol content material and antioxidant actions (ABTS, DPPH, and FRAP) and ACE inhibitory exercise (in vitro antihypertensive exercise) have been evaluated after every stage of digestion, with values higher than 80% of exercise earlier than gastrointestinal transit and with values higher than 55% exercise after the top of gastrointestinal transit. Gastrointestinal analysis of the encapsulated extracts was carried out with an ex vivo mannequin utilizing pig intestines and simulating the circumstances of digestion in three phases: the gastric (pH 2.Zero with 1.
Zero M HCl +0.5 g/L pepsin), enteric (pH 8.Zero with Krebs resolution +1.Zero mL/L bile) and last enteric (pH 7.5 Krebs resolution solely) phases. The microencapsulation of passionflower extracts confirmed good conduct in opposition to adjustments in pH and enzymatic actions all through digestion, thus selling a managed launch and focused supply of bioactive compounds, present process a paracellular mechanism by means of the intestinal barrier to protect the antioxidant exercise and ACE inhibitory that was proven by the extracts earlier than encapsulation of the fabric.
The impact of UV radiation on O-7 Actinomycete in producing bioactive compounds in numerous development circumstances
Actinomycetes have been recognized as an origin of many secondary metabolites, antibiotics and energetic parts that influence microbial development. Mediated mutations utilizing UV in follow for the breeding of organisms. The target of this examine is to analyses the influence of UV radiation on the (O-7) Actinomycete isolate. This was a potential analytical examine of a a number of of actinomycetes. The isolates have been screened for antimicrobial efficacy in opposition to a number of Gram-positive, Gram-negative micro organism, yeast, and fungi. Varied elements resembling UV, temperature, pH, gentle, agitation, fermentation durations and aeration have additionally been boosted for optimum antimicrobial manufacturing.
The isolate (O-7) Actinomycete has been acknowledged as a extremely bioactive producing organism. The isolate was uncovered to numerous wavelengths, instances underneath quite a few development circumstances. It was discovered that 4% focus of glucose as a carbon supply is considerably optimum for the manufacturing of antibiotic for (O-7) UV uncovered pressure, nonetheless, focus of 1% of lactose is considerably optimum for the manufacturing of antibiotic for (O-7) UV uncovered pressure. Yeast extract at a focus of 1% was discovered to be the very best supply of nitrogen for (O-7) UV uncovered, whereas pH 7.
Zero was discovered to be probably the most appropriate for a similar isolate. From the temperature optimization examine, it was noticed that (O-7) uncovered pressure confirmed good development and most antibiotic manufacturing at 28 °C. The soil-isolated organic compounds (O-7) have been efficient in opposition to sure sorts of micro organism and fungi, and the analysis additionally demonstrated that publicity to UV radiation enhanced the manufacturing of those compounds.Elucidating the switch of bioactive compounds between crops is important for understanding plant-plant interactions, growing pure pesticides and understanding their modes of motion. This text is protected by copyright. All rights reserved.
Translocation of metabolites between completely different plant species gives necessary hints in understanding the destiny of bioactive root exudates. Within the current examine, focused and untargeted mass spectrometry-based metabolomics was utilized to elucidate the switch of bioactive compounds between rye and a number of other crops and weed species. Our outcomes demonstrated that benzoxazinoids (BXs) synthesized by rye have been taken up by roots of neighbouring plant species and translocated into their shoots.
GPAT2 Recombinant Protein (Mouse) |
|||
RP139238 | ABM | 100 ug | Ask for price |
Gpat2 ORF Vector (Rat) (pORF) |
|||
ORF067727 | ABM | 1.0 ug DNA | EUR 607.2 |
GPAT2 ORF Vector (Human) (pORF) |
|||
ORF020318 | ABM | 1.0 ug DNA | Ask for price |
Gpat2 ORF Vector (Mouse) (pORF) |
|||
ORF046414 | ABM | 1.0 ug DNA | EUR 607.2 |
Gpat2 sgRNA CRISPR Lentivector set (Rat) |
|||
K6080101 | ABM | 3 x 1.0 ug | EUR 406.8 |
Gpat2 sgRNA CRISPR Lentivector set (Mouse) |
|||
K3673901 | ABM | 3 x 1.0 ug | EUR 406.8 |
GPAT2 sgRNA CRISPR Lentivector set (Human) |
|||
K2772901 | ABM | 3 x 1.0 ug | EUR 406.8 |
Gpat2 sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
K6080102 | ABM | 1.0 ug DNA | EUR 184.8 |
Gpat2 sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
K6080103 | ABM | 1.0 ug DNA | EUR 184.8 |
Gpat2 sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
K6080104 | ABM | 1.0 ug DNA | EUR 184.8 |
Gpat2 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
K3673902 | ABM | 1.0 ug DNA | EUR 184.8 |
Gpat2 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
K3673903 | ABM | 1.0 ug DNA | EUR 184.8 |
Gpat2 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
K3673904 | ABM | 1.0 ug DNA | EUR 184.8 |
GPAT2 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
K2772902 | ABM | 1.0 ug DNA | EUR 184.8 |
GPAT2 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
K2772903 | ABM | 1.0 ug DNA | EUR 184.8 |
GPAT2 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
K2772904 | ABM | 1.0 ug DNA | EUR 184.8 |
GPAT2 Protein Vector (Human) (pPB-C-His) |
|||
PV081269 | ABM | 500 ng | Ask for price |
GPAT2 Protein Vector (Human) (pPB-N-His) |
|||
PV081270 | ABM | 500 ng | Ask for price |
GPAT2 Protein Vector (Human) (pPM-C-HA) |
|||
PV081271 | ABM | 500 ng | Ask for price |
GPAT2 Protein Vector (Human) (pPM-C-His) |
|||
PV081272 | ABM | 500 ng | Ask for price |
GPAT2 Protein Vector (Mouse) (pPB-C-His) |
|||
PV185654 | ABM | 500 ng | EUR 1278 |
GPAT2 Protein Vector (Mouse) (pPB-N-His) |
|||
PV185655 | ABM | 500 ng | EUR 1278 |
GPAT2 Protein Vector (Mouse) (pPM-C-HA) |
|||
PV185656 | ABM | 500 ng | EUR 1278 |
GPAT2 Protein Vector (Mouse) (pPM-C-His) |
|||
PV185657 | ABM | 500 ng | EUR 1278 |
GPAT2 Protein Vector (Rat) (pPB-C-His) |
|||
PV270906 | ABM | 500 ng | EUR 1399.2 |
GPAT2 Protein Vector (Rat) (pPB-N-His) |
|||
PV270907 | ABM | 500 ng | EUR 1399.2 |
GPAT2 Protein Vector (Rat) (pPM-C-HA) |
|||
PV270908 | ABM | 500 ng | EUR 1399.2 |
GPAT2 Protein Vector (Rat) (pPM-C-His) |
|||
PV270909 | ABM | 500 ng | EUR 1399.2 |
GPAT2 3'UTR Luciferase Stable Cell Line |
|||
TU009103 | ABM | 1.0 ml | EUR 2799.6 |
Gpat2 3'UTR GFP Stable Cell Line |
|||
TU255284 | ABM | 1.0 ml | Ask for price |
GPAT2 3'UTR GFP Stable Cell Line |
|||
TU059103 | ABM | 1.0 ml | EUR 2799.6 |
Gpat2 3'UTR Luciferase Stable Cell Line |
|||
TU205284 | ABM | 1.0 ml | Ask for price |
Gpat2 3'UTR Luciferase Stable Cell Line |
|||
TU108926 | ABM | 1.0 ml | Ask for price |
Gpat2 3'UTR GFP Stable Cell Line |
|||
TU158926 | ABM | 1.0 ml | Ask for price |
Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
K6080105 | ABM | 3 x 1.0 ug | EUR 451.2 |
Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
K3673905 | ABM | 3 x 1.0 ug | EUR 451.2 |
GPAT2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
K2772905 | ABM | 3 x 1.0 ug | EUR 451.2 |
Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|||
K6080106 | ABM | 1.0 ug DNA | EUR 200.4 |
Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
|||
K6080107 | ABM | 1.0 ug DNA | EUR 200.4 |
Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
|||
K6080108 | ABM | 1.0 ug DNA | EUR 200.4 |
Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
K3673906 | ABM | 1.0 ug DNA | EUR 200.4 |
Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
K3673907 | ABM | 1.0 ug DNA | EUR 200.4 |
Gpat2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
K3673908 | ABM | 1.0 ug DNA | EUR 200.4 |
GPAT2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
K2772906 | ABM | 1.0 ug DNA | EUR 200.4 |
GPAT2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
K2772907 | ABM | 1.0 ug DNA | EUR 200.4 |
GPAT2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
K2772908 | ABM | 1.0 ug DNA | EUR 200.4 |
CD11b Antibody Antibody |
|||
ABD2911 | Lifescience Market | 100 ug | EUR 525.6 |
ASAP1 antibody Antibody |
|||
DF8746 | Affbiotech | 200ul | EUR 420 |
anti- Antibody^Polyclonal antibody control antibody |
|||
LSMab09882 | Lifescience Market | 100 ug | EUR 525.6 |
ARHGDIA Antibody / RHOGDI Antibody |
|||
F54788-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 165 |
ARHGDIA Antibody / RHOGDI Antibody |
|||
F54788-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 379 |
Antibody |
|||
A1360-500 | Biovision | each | Ask for price |
Anti-Glycolipid Antibody (AGA) Antibody |
|||
20-abx004855 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
20-abx008109 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
20-abx123734 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
20-abx014333 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
abx033330-400ul | Abbexa | 400 ul | EUR 627.6 |
Ly1 Antibody Reactive (LYAR) Antibody |
|||
abx033330-80l | Abbexa | 80 µl | EUR 343.2 |
Anti-Glycolipid Antibody (AGA) Antibody |
|||
abx036399-100ug | Abbexa | 100 ug | EUR 469.2 |
Anti-Glycoprotein Antibody (GP) Antibody |
|||
20-abx319900 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody |
|||
20-abx319901 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody |
|||
20-abx319905 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody |
|||
20-abx319913 | Abbexa |
|
|
Anti-Glycolipid Antibody (AGA) Antibody |
|||
abx230204-100ug | Abbexa | 100 ug | EUR 577.2 |
Ly1 Antibody Reactive (LYAR) Antibody |
|||
20-abx324434 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
20-abx311665 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
|||
abx234901-100ug | Abbexa | 100 ug | EUR 661.2 |
Anti-Anti-SEPT6 antibody antibody |
|||
STJ11100949 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined. |
Anti-Anti-SEPT9 Antibody antibody |
|||
STJ111369 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described. |
Anti-Anti-SEPT11 Antibody antibody |
|||
STJ111530 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT4 Antibody antibody |
|||
STJ112276 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer. |
Anti-Anti-MARCH9 Antibody antibody |
|||
STJ112609 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT11 Antibody antibody |
|||
STJ113941 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT11 Antibody antibody |
|||
STJ114081 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT5 Antibody antibody |
|||
STJ114819 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
Anti-Anti-MARCH8 Antibody antibody |
|||
STJ114828 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT7 Antibody antibody |
|||
STJ116214 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
Anti-Anti-SEPT8 Antibody antibody |
|||
STJ117206 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-SEPT12 Antibody antibody |
|||
STJ117759 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-MARCH6 Antibody antibody |
|||
STJ118549 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-MARCH6 Antibody antibody |
|||
STJ118550 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-MARCH7 Antibody antibody |
|||
STJ118752 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT3 Antibody antibody |
|||
STJ118990 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT2 Antibody antibody |
|||
STJ28365 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT7 Antibody antibody |
|||
STJ28963 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
Anti-Anti-SEPT2 Antibody antibody |
|||
STJ25475 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT5 Antibody antibody |
|||
STJ25477 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
Anti-Anti-SEPT8 Antibody antibody |
|||
STJ25479 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-SEPT1 antibody antibody |
|||
STJ119580 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012] |
CLCN5 Antibody / CIC-5 antibody |
|||
RQ6462 | NSJ Bioreagents | 100ug | EUR 419 |
Description: The CLCN5 gene encodes the chloride channel Cl-/H+ exchanger ClC-5. This gene encodes a member of the ClC family of chloride ion channels and ion transporters. The encoded protein is primarily localized to endosomal membranes and may function to facilitate albumin uptake by the renal proximal tubule. Mutations in this gene have been found in Dent disease and renal tubular disorders complicated by nephrolithiasis. Alternatively spliced transcript variants have been found for this gene. |
Cytokeratin 7 antibody-Cytoskeleton Marker Antibody |
|||
48169-100ul | SAB | 100ul | EUR 399.6 |
Cytokeratin 7 antibody-Cytoskeleton Marker Antibody |
|||
48169-50ul | SAB | 50ul | EUR 286.8 |
Anti CD22 Antibody: CD22 Monoclonal Antibody |
|||
065-A-01mg | Virogen | 0,1 mg | EUR 321 |
Description: anti-CD22 monoclonal antibody |
Anti CD22 Antibody: CD22 Monoclonal Antibody |
|||
065-A-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: anti-CD22 monoclonal antibody |
Antibody Pair to ApoA-V antibody |
|||
10R-1876 | Fitzgerald | 100 ul | EUR 781.2 |
Description: Mouse monoclonal Antibody Pair to ApoA-V antibody |
Ly1 Antibody Reactive Homolog (LYAR) Antibody |
|||
20-abx103034 | Abbexa |
|
|
Ly1 Antibody Reactive Homolog (LYAR) Antibody |
|||
20-abx103035 | Abbexa |
|
|
Ly1 Antibody Reactive Homolog (LYAR) Antibody |
|||
20-abx103036 | Abbexa |
|
|
Hepatitis C Virus Antibody (HCV) Antibody |
|||
abx023924-1mg | Abbexa | 1 mg | EUR 1446 |
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
|||
20-abx319902 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
|||
20-abx319903 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
|||
20-abx319904 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
|||
20-abx319906 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
|||
20-abx319907 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
|||
20-abx319908 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
|||
20-abx319914 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
|||
20-abx319915 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
|||
20-abx319916 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
|||
20-abx319929 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
|||
20-abx319930 | Abbexa |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
|||
20-abx319931 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody (HRP) |
|||
20-abx311666 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody (FITC) |
|||
20-abx311667 | Abbexa |
|
|
Ly1 Antibody Reactive (LYAR) Antibody (Biotin) |
|||
20-abx311668 | Abbexa |
|
|
Anti-Glycoprotein 210 Antibody (gp210) Antibody |
|||
abx233571-100ug | Abbexa | 100 ug | EUR 577.2 |
Anti Deoxyribonucleic Acid Antibody (DNA) Antibody |
|||
abx411057-50ug | Abbexa | 50 ug | EUR 710.4 |
Monoclonal NGF/proNGF Neutralizing Antibody Antibody |
|||
AMM06679G | Leading Biology | 0.05mg | EUR 633.6 |
Description: A Monoclonal antibody against Human NGF/proNGF Neutralizing. The antibodies are raised in Mouse. This antibody is applicable in E |
Goat anti- human Antibody^Polyclonal antibody |
|||
LSMab09896 | Lifescience Market | 100 ug | EUR 525.6 |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D | Stressmarq | 0.1mg | EUR 424.8 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is unconjugated. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A390 | Stressmarq | 0.1mg | EUR 481.2 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 390. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A488 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 488. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A565 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 565. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A594 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 594. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A633 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 633. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A655 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 655. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A680 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 680. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-A700 | Stressmarq | 0.1mg | EUR 480 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 700. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-ALP | Stressmarq | 0.1mg | EUR 472.8 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Alkaline Phosphatase. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-APC | Stressmarq | 0.1mg | EUR 478.8 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to APC . |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-APCCY7 | Stressmarq | 0.1mg | EUR 565.2 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to APC/Cy7. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-BI | Stressmarq | 0.1mg | EUR 475.2 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Biotin. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-DY350 | Stressmarq | 0.1mg | EUR 496.8 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Dylight 350. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-DY405 | Stressmarq | 0.1mg | EUR 483.6 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Dylight 405. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-DY488 | Stressmarq | 0.1mg | EUR 471.6 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Dylight 488. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-DY594 | Stressmarq | 0.1mg | EUR 474 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Dylight 594. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-DY633 | Stressmarq | 0.1mg | EUR 468 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Dylight 633. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-FITC | Stressmarq | 0.1mg | EUR 470.4 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to FITC. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-HRP | Stressmarq | 0.1mg | EUR 465.6 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to HRP. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-P594 | Stressmarq | 0.1mg | EUR 488.4 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to PE/ATTO 594. |
Antibody for Human alpha Tubulin Antibody |
|||
SPC-692D-PCP | Stressmarq | 0.1mg | EUR 478.8 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to PerCP. |
Moreover, we confirmed that roots of rye crops took up compounds originating from neighbouring crops. Among the many compounds taken up by rye roots, wogonin was detected within the rye shoot, which indicated a root-to-shoot translocation of this compound.